China’s 15th Five-Year Medical Security Plan: Implications for Pharma and MedTech Strategy Through 2030

China has now set out its medical security priorities through 2030. This analysis looks beyond the policy language to examine what the emerging direction could mean for pharmaceutical and MedTech manufacturers planning for the Chinese market.

With the release of China’s National Medical Security 15th Five-Year Plan (2026-2030), the direction of healthcare security policy is coming into sharper focus. The plan serves as the sector-specific implementation framework for the broader national 15th Five-Year Plan, translating high-level medical security objectives into concrete priorities across coverage, payment, pricing, procurement, fund management, and the development of a multi-level medical security system.

This analysis provides a comprehensive strategic read of the plan, examining how these priorities fit together and what they may mean for pharmaceutical and MedTech manufacturers over the next five years.

Within that broader assessment, it focuses on three cross-cutting themes: standardization, expansion of reform reach, and more differentiated policy support for medical technology innovation and commercial insurance.

Not yet a member?

Access360 membership provides structured intelligence on China’s evolving health policy, coverage, and financing system, with member briefings, archive access, and opportunities to submit questions on published analyses.

Explore Membership